Carillon Tower Advisers’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-360,500
Closed -$13.4M 468
2019
Q1
$13.4M Buy
+360,500
New +$13.1M 0.09% 293
2018
Q4
Sell
-162,300
Closed -$6.4M 460
2018
Q3
$6.4M Sell
162,300
-47,875
-23% -$2.09M 0.05% 362
2018
Q2
$9.32M Sell
210,175
-106,275
-34% -$5.29M 0.07% 330
2018
Q1
$15.4M Buy
+316,450
New +$15.8M 0.12% 236

Other funds holding CC

Carillon Tower Advisers's CC Position: Q2 2019 in Review

Carillon Tower Advisers sold out of Chemours (CC) in Q2 2019, closing a stake of 360,500 shares — an estimated $13.4M sold.

Carillon Tower Advisers first reported a position in CC in Q1 2018 and held it in 4 quarters. The position peaked at $15.4M in Q1 2018. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Carillon Tower Advisers reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 360,500 Chemours shares in Q2 2019, an estimated $13.4M.
  • Carillon Tower Advisers first reported a position in Chemours in Q1 2018 and held it in 4 quarters.
  • Carillon Tower Advisers's Chemours position peaked at $15.4M in Q1 2018.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Carillon Tower Advisers's 13F filing for Q2 2019, filed 8 Aug 2019.